LEWIS JOEL (CIK 1725595) reported 22 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-01-13). Recent activity: Sell GALT (56,332 shares), Buy GALT (84,000 shares), Sell GALT (18,571 shares), Sell GALT (27,731 shares), Sell GALT (37,698 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-13 | GALECTIN THERAPEUTICS INC (GALT) | President and CEO | Sell | 56,332 | $218,568 |
| 2026-01-06 | GALECTIN THERAPEUTICS INC (GALT) | President and CEO | Buy | 84,000 | $0 |
| 2026-01-06 | GALECTIN THERAPEUTICS INC (GALT) | President and CEO | Sell | 18,571 | $77,998 |
| 2026-01-06 | GALECTIN THERAPEUTICS INC (GALT) | President and CEO | Sell | 27,731 | $108,428 |
| 2026-01-06 | GALECTIN THERAPEUTICS INC (GALT) | President and CEO | Sell | 37,698 | $134,959 |
| 2025-12-19 | GALECTIN THERAPEUTICS INC (GALT) | President and CEO | Buy | 7,829 | $22,391 |
| 2025-12-19 | GALECTIN THERAPEUTICS INC (GALT) | President and CEO | Sell | 7,829 | $55,273 |
| 2025-11-19 | GALECTIN THERAPEUTICS INC (GALT) | President and CEO | Buy | 15,680 | $37,475 |
| 2025-11-19 | GALECTIN THERAPEUTICS INC (GALT) | President and CEO | Sell | 15,680 | $94,707 |
| 2025-11-19 | GALECTIN THERAPEUTICS INC (GALT) | President and CEO | Buy | 6,783 | $16,211 |
| 2025-11-19 | GALECTIN THERAPEUTICS INC (GALT) | President and CEO | Sell | 6,783 | $41,715 |
| 2025-11-12 | GALECTIN THERAPEUTICS INC (GALT) | President and CEO | Buy | 1,867 | $4,462 |
| 2025-11-12 | GALECTIN THERAPEUTICS INC (GALT) | President and CEO | Sell | 1,867 | $11,258 |
| 2025-11-07 | GALECTIN THERAPEUTICS INC (GALT) | President and CEO | Buy | 200 | $478 |
| 2025-11-07 | GALECTIN THERAPEUTICS INC (GALT) | President and CEO | Sell | 200 | $1,200 |
| 2025-11-05 | GALECTIN THERAPEUTICS INC (GALT) | President and CEO | Buy | 1,300 | $3,107 |
| 2025-11-05 | GALECTIN THERAPEUTICS INC (GALT) | President and CEO | Sell | 1,300 | $7,813 |
| 2025-11-05 | GALECTIN THERAPEUTICS INC (GALT) | President and CEO | Buy | 14,420 | $34,464 |
| 2025-11-05 | GALECTIN THERAPEUTICS INC (GALT) | President and CEO | Sell | 14,420 | $87,529 |
| 2025-09-15 | GALECTIN THERAPEUTICS INC (GALT) | President and CEO | Buy | 14,000 | $33,460 |
| 2025-09-15 | GALECTIN THERAPEUTICS INC (GALT) | President and CEO | Sell | 14,000 | $89,040 |
| 2025-03-05 | GALECTIN THERAPEUTICS INC (GALT) | President and CEO | Sell | 56,420 | $88,579 |
Source: SEC Form 4 filings · as of 2026-01-13